Atsushi Tanaka, H. Teragawa, T. Takamura, T. Maruhashi, M. Yamaoka-Tojo, Junya Ako, K. Yufu, N. Takahashi, H. Tomiyama, Y. Higashi, K. Node
{"title":"附加恩格列净对2型糖尿病和心血管疾病患者动脉硬化的影响:来自安慰剂对照的EMBLEM试验的分析","authors":"Atsushi Tanaka, H. Teragawa, T. Takamura, T. Maruhashi, M. Yamaoka-Tojo, Junya Ako, K. Yufu, N. Takahashi, H. Tomiyama, Y. Higashi, K. Node","doi":"10.30548/vascfail.6.1_1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":126642,"journal":{"name":"Vascular Failure","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of add-on empagliflozin on arterial stiffness in patients with type 2 diabetes and cardiovascular disease: an analysis from a placebo-controlled EMBLEM trial\",\"authors\":\"Atsushi Tanaka, H. Teragawa, T. Takamura, T. Maruhashi, M. Yamaoka-Tojo, Junya Ako, K. Yufu, N. Takahashi, H. Tomiyama, Y. Higashi, K. Node\",\"doi\":\"10.30548/vascfail.6.1_1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":126642,\"journal\":{\"name\":\"Vascular Failure\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Failure\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30548/vascfail.6.1_1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Failure","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30548/vascfail.6.1_1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effect of add-on empagliflozin on arterial stiffness in patients with type 2 diabetes and cardiovascular disease: an analysis from a placebo-controlled EMBLEM trial